Results 201 to 210 of about 1,150,712 (337)
Biodegradable polymer luteinising hormone releasing hormone analogue for prostatic cancer: use of a new peptide delivery system. [PDF]
G. Williams+4 more
openalex +1 more source
The expression of integrin β4 (ITGβ4) on small extracellular vesicle (sEV) correlates with lung‐tropism. Enrichment of ITGβ4 on sEVs enhances their lung‐targeting ability. The sEVs loaded with doxorubicin exhibit superior therapeutic efficacy in a lung metastasis mouse model.
Tung Him Ng+7 more
wiley +1 more source
Controversies in metastatic hormone-sensitive prostate cancer. [PDF]
Tsung I, Yentz SE, Reichert ZR.
europepmc +1 more source
AN UNUSUAL BLEEDING IN THE COURSE OF HONVAN THERAPY OF PROSTATIC CANCER
Kango Oda, Keiichi Ueda, Tokio Higashi
openalex +2 more sources
Multiple primary tumors in association with prostatic cancer [PDF]
Arthur S. Liskow+5 more
openalex +1 more source
This work explores the MOF landscape to select a single, optimal candidate for successfully delivering cancer drugs (gemcitabine, paclitaxel, SN‐38) into tough pancreatic tumors. Machine learning and simulations guide this search, demonstrating colloidal stability, excellent biocompatibility, cellular uptake, and sustained release.
Francesca Melle+9 more
wiley +1 more source
Artificial intelligence in prostate cancer. [PDF]
Li W+13 more
europepmc +1 more source
Acute gastrointestinal bleeding as the presenting manifestation of prostate Cancer [PDF]
Donald C. Doll+2 more
openalex +1 more source